Evidence map›Paper›PMID 24152066›Full record

ArticleACS nano2013

Engineered nanopore of Phi29 DNA-packaging motor for real-time detection of single colon cancer specific antibody in serum.

Shaoying Wang, Farzin Haque, Piotr G Rychahou, B Mark Evers, Peixuan Guo

Abstract read
In one paragraph

Article in ACS nano, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 56 papers.

0numbers the graph read from it
0cells of the map it votes in
56citing papers in PubMed
5.9field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

56 citing papers in PubMed, 128 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Nipple fluid for breast cancer diagnosis using the nanopore of Phi29 DNA-packaging motor.Nanomedicine : nanotechnology, biology, and medicine · 2023
    Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Nanopore Technology for the Application of Protein Detection.Nanomaterials (Basel, Switzerland) · 2021
    Review
  15. Article
  16. Biological Nanopores: Engineering on Demand.Life (Basel, Switzerland) · 2021
    Review
  17. Lysenin Channels as Sensors for Ions and Molecules.Sensors (Basel, Switzerland) · 2020
    Review
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Shaoying WangNanobiotechnology Center, ‡Department of Pharmaceutical Sciences, College of Pharmacy, and §Markey Cancer Center, University of Kentucky , Lexington, Kentucky 40536, United States.
Farzin Haque
Piotr G Rychahou
B Mark Evers
Peixuan Guo
Markey Cancer Center · USUniversity of Kentucky · US

Funding

Phi29 Motor Nanopore for Single Molecule Sensing and dsDNA FingerprintingR01EB012135 · NIBIB · UNIVERSITY OF KENTUCKY · PI GUO, PEIXUAN · 2011 to 2019
$2.6M
NIBIB NIH HHS EB012135NIBIB NIH HHS R01 EB012135
6 · The paper itself

Abstract

The ingenious design of the bacterial virus phi29 DNA packaging nanomotor with an elegant and elaborate channel has inspired its application for single molecule detection of antigen/antibody interactions. The hub of this bacterial virus nanomotor is a truncated cone-shaped connector consisting of 12 protein subunits. These subunits form a ring with a central 3.6-nm channel acting as a path for dsDNA to enter during packaging and to exit during infection. The connector has been inserted into a lipid bilayer. Herein, we reengineered an Epithelial Cell Adhesion Molecule (EpCAM) peptide into the C-terminal of nanopore as a probe to specifically detect EpCAM antibody (Ab) in nanomolar concentration at the single molecule level. The binding of Abs sequentially to each peptide probe induced stepwise blocks in current. The distinctive current signatures enabled us to analyze the docking and undocking kinetics of Ab-probe interactions and determine the Kd. The signal of EpCAM antibody can be discriminated from the background events in the presence of nonspecific antibody or serum. Our results demonstrate the feasibility of generating a highly sensitive platform for detecting antibodies at extremely low concentrations in the presence of contaminants.

Indexed as

NanoporesAnimalsAntibodiesAntigens, NeoplasmBacillus PhagesBiomarkers, TumorCell Adhesion MoleculesColonic NeoplasmsDNA PackagingDNA, ViralElectrodesEpithelial Cell Adhesion MoleculeKineticsLipid BilayersMaleMiceAntibodiesAntigens, NeoplasmBiomarkers, TumorCell Adhesion MoleculesDNA, ViralEpithelial Cell Adhesion MoleculeLipid BilayersPeptides

Identifiers

PMID24152066
PMCPMC3915501
OpenAlexW2063962302

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.